胜任细胞市场规模、份额、成长分析，按类型、按应用、按最终用户、按地区 - 行业预测，2025-2032 年

2023年胜任细胞的全球市场规模为21.3亿美元，从2024年的23亿美元增长到2032年的42.9亿美元，预计在预测期内（2025-2032年）复合年增长率为8.1%。为美元。

由于公共和私营部门对分子克隆研究的投资不断增加，全球胜任细胞市场正在显着成长。大肠桿菌具有透过氯化钙和热激技术整合染色体外DNA的独特能力，这使其对研究人员具有吸引力。这些方法创建渗透性的细胞壁并促进 DNA 转化，这对于各种应用至关重要。此外，消费者对分子克隆产品的需求不断增长，加上医疗保健支出的增加以及对此类解决方案的认识不断增强，进一步推动了市场扩张。政府支持研究经费和人口成长的措施也对市场动态做出了积极贡献，为感受态细胞技术的创新和开发创造了良好的环境。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 价格分析
• 技术分析
• 监管分析
• 专利分析
• 案例研究

胜任细胞市场规模：依类型

• 市场概况
• 化学胜任细胞
• 电感受态胜任细胞

胜任细胞市场规模：依应用分类

• 市场概况
• 复製
• 亚克隆和常规克隆
• 噬菌体展示库的构建
• 有毒/不稳定的 DNA 克隆
• 高通量克隆
• 蛋白质表现
• 其他用途
• 诱变
• 单链DNA 的生成
• 慢病毒载体的生产
• 大质体转化

胜任细胞市场规模：依最终用户划分

• 市场概况
• 製药和生物技术公司
• 学术研究所
• 合约研究组织（CRO）

胜任细胞市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Merck KGaA（Germany）
• Promega Corporation（US）
• Thermo Fisher Scientific, Inc.（US）
• New England Biolabs（US）
• Takara Bio（Japan）
• Agilent Technologies（US）
• Lucigen（Epicenter）（Illumina）（US）
• QIAGEN NV（Germany）
• OriGene Technologies（US）
• Bioline（UK）
• Zymo Research（US）
• Beijing TransGen Biotech Co., Ltd.（China）
• Source BioScience（UK）
• IBA GmbH（Germany）
• Genewiz（US）
• BioDynamics Laboratory, Inc.（Japan）
• GCC Biotech（India）
• SMOBIO Technology（Taiwan）
• GeneScript Corporation（US）
• Bio-Rad Laboratories（US）

结论和建议

Global Competent Cells Market size was valued at USD 2.13 billion in 2023 and is poised to grow from USD 2.3 billion in 2024 to USD 4.29 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global competent cells market is experiencing significant growth, driven by increased investments from both public and private sectors in molecular cloning research. E. coli's unique ability to integrate extrachromosomal DNA through techniques involving calcium chloride and heat shock is compelling for researchers. These methods create permeable cell walls, facilitating DNA transformation essential for various applications. Additionally, rising consumer demand for molecularly cloned products, coupled with growing healthcare expenditures and heightened awareness of these solutions, further bolsters market expansion. Government initiatives supporting research funding and population growth also contribute positively to the market's dynamics, underscoring a robust environment for innovation and development in competent cell technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Competent Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Competent Cells Market Segmental Analysis

Global Competent Cells Market is segmented by Type, Application, End User and region. Based on Type, the market is segmented into Chemically Competent Cells and Electrocompetent Cells. Based on Application, the market is segmented into Cloning, Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, High-throughput Cloning, Protein Expression, Other Applications, Mutagenesis, Single-stranded DNA Production, Lentiviral Vector Production and Large Plasmid Transformation. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Competent Cells Market

The global competent cells market is poised for growth, largely propelled by favorable government initiatives and the surging demand for products developed through recombinant DNA technology, alongside advancements in molecular engineering. Over the coming years, this market is expected to thrive due to heightened research and development efforts aimed at creating therapeutic items addressing various health conditions, coupled with beneficial reimbursement and regulatory frameworks. Furthermore, a growing commercial interest in molecularly cloned products and recombinant proteins, alongside increased government investment in research activities, is anticipated to significantly enhance market potential throughout the next decade.

Restraints in the Global Competent Cells Market

The Global Competent Cells market is likely to face several constraints hindering its growth. One significant factor is the high cost associated with competent cell kits, which can deter potential market entrants and limit accessibility for smaller research facilities. Furthermore, the increasing market consolidation is raising entry barriers, making it challenging for new players to compete. Compounding these issues, a shortage of skilled professionals with expertise in this field is expected to pose an additional challenge during the forecast period, ultimately impeding the overall expansion of the competent cells market.

Market Trends of the Global Competent Cells Market

The Global Competent Cells market is poised for significant growth, driven by the rising demand for molecular cloning applications across various sectors. Increasing investments in cloning research, coupled with financial support from governmental and private organizations, are propelling advancements in cell engineering techniques like somatic cell nuclear transfer (SCNT). These technologies are pivotal in producing transgenic animals, preserving endangered species, and advancing therapeutic cloning. As competent cells play a crucial role in these innovative research areas, the market is expected to attract renewed interest and investment, resulting in a robust upward trend in demand for competent cells worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Competent Cells Market Size by Type & CAGR (2025-2032)

• Market Overview
• Chemically Competent Cells
• Electrocompetent Cells

Global Competent Cells Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cloning
• Subcloning & Routine Cloning
• Phage Display Library Construction
• Toxic/Unstable DNA Cloning
• High-throughput Cloning
• Protein Expression
• Other Applications
• Mutagenesis
• Single-stranded DNA Production
• Lentiviral Vector Production
• Large Plasmid Transformation

Global Competent Cells Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations (CROs)

Global Competent Cells Market Size & CAGR (2025-2032)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lucigen (Epicenter) (Illumina) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing TransGen Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Source BioScience (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioDynamics Laboratory, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GCC Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMOBIO Technology (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneScript Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations